Skip to main content
Signal8

Lloyd Marcea Bland

SEC insider (Form 3/4/5 filer). CIK 0001389208. Director at Poseida Therapeutics, Inc. (PSTX). 9 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2025. Located in SAN DIEGO, CA.

Companies Lloyd Marcea Bland has filed insider reports for

  • Poseida Therapeutics, Inc. (PSTX): Director
Lloyd Marcea Bland profile photo

Lloyd Marcea Bland

CIK: 0001389208

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Poseida Therapeutics, Inc. logo
PSTX

Poseida Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Tender Offer
    Direct
    69K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    32.1K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    16K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    20K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    20K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    25.8K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    28.5K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    27.4K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    27.4K shares-

1-9 of 9